What did @ojayto actually say?
The creator walked viewers through reconstituting retatrutide powder using bacteriostatic water, explaining a simple ratio: add 1 mL of bacteriostatic water to a 5 mg vial so that "every 20 units on my syringe is going to be a 1 milligram dose." For a 10 mg vial, they said to use 2 mL. That is essentially the whole video.
What the video does not say is also important. There is no mention of what retatrutide actually is, no discussion of who it is intended for, no sourcing guidance, no storage instructions after reconstitution, and no acknowledgment that this compound is not FDA-approved and is only available as a compounded or research-grade substance. The video is framed as a helpful how-to, but it skips essentially every safety-relevant detail.
Does the science back this up?
The reconstitution math itself is correct. The dosing arithmetic the creator describes is standard pharmacy-level dilution logic and does not require a study to validate. However, the broader context of retatrutide use is where things get complicated.
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors. In a 2023 Phase 2 trial published in the New England Journal of Medicine (Jastreboff et al., 2023, NEJM), participants receiving 12 mg weekly doses lost an average of 24.2% of body weight over 48 weeks, which was notable. But that trial used a specific pharmaceutical-grade formulation administered under medical supervision with dose escalation protocols. The compound available through compounding pharmacies or gray-market peptide suppliers is not the same product used in those trials. Potency, purity, and sterility cannot be assumed equivalent.
What did they get wrong (or right)?
The math is right. 1 mL into a 5 mg vial does yield 1 mg per 20 units on a standard U-100 insulin syringe. Credit where it is due.
But the framing is the problem. The creator presents this as a routine skill anyone can pick up from a TikTok, with no acknowledgment of the risks involved in self-injecting an unregulated compound. There is no mention of injection site care, no guidance on recognizing adverse reactions like nausea, tachycardia, or hypoglycemia, and no recommendation to involve a clinician.
More specifically, the video does not address:
- The difference between pharmaceutical-grade and compounded or research-grade retatrutide
- Storage requirements after reconstitution (typically refrigerated, used within 28-30 days)
- That "backwater" (bacteriostatic water) itself has a shelf life and must be handled with sterile technique
- That retatrutide has not received FDA approval as of this writing
Getting the dilution ratio right while ignoring everything else is a partial credit situation at best.
What should you actually know?
Retatrutide is one of the more aggressively studied GLP-1-class compounds in the pipeline, and the Phase 2 data is genuinely interesting to researchers and clinicians. But interesting Phase 2 data is not the same as an approved, safety-characterized treatment.
The reconstitution technique shown here, mixing lyophilized peptide with bacteriostatic water and drawing doses with an insulin syringe, is a real practice in clinical and compounding contexts. Done correctly under proper guidance, it is a learnable skill. Done incorrectly or with contaminated supplies, it carries real infection and dosing error risks.
If you are considering any GLP-1-class peptide therapy, including retatrutide, the starting point should be a licensed clinician who can evaluate your health history, monitor for side effects, and source compounds from a verified, regulated pharmacy. A TikTok comment section is not a substitute for that process.